scholarly journals Leptin signaling and the intervertebral disc: Sex dependent effects of leptin receptor deficiency and Western diet on the spine in a type 2 diabetes mouse model

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0227527 ◽  
Author(s):  
Devorah M. Natelson ◽  
Alon Lai ◽  
Divya Krishnamoorthy ◽  
Robert C. Hoy ◽  
James C. Iatridis ◽  
...  
2019 ◽  
Author(s):  
Devorah M. Natelson ◽  
Alon Lai ◽  
Divya Krishnamoorthy ◽  
Rob C. Hoy ◽  
James C. Iatridis ◽  
...  

AbstractType 2 diabetes and obesity are associated with back pain in juveniles and adults and are implicated in intervertebral disc (IVD) degeneration. Hypercaloric Western diets are associated with both obesity and type 2 diabetes. The objective of this study was to determine if obesity and type 2 diabetes result in spinal pathology in a sex-specific manner using in vivo diabetic and dietary mouse models. Leptin is an appetite-regulating hormone, and its deficiency leads to polyphagia, resulting in obesity and diabetes. Leptin is also associated with IVD degeneration, and increased expression of its receptor was identified in degenerated IVDs. We used young, leptin receptor deficient (Db/Db) mice to mimic the effect of diet and diabetes on adolescents. Db/Db and Control mice were fed either Western or Control diets, and were sacrificed at 3 months of age. Db/Db mice were obese, while only female mice developed diabetes. Female Db/Db mice displayed altered IVD morphology, with increased intradiscal notochordal band area, suggesting delayed IVD cell proliferation and differentiation, rather than IVD degeneration. Motion segments from Db/Db mice exhibited increased failure risk with decreased torsional failure strength. Db/Db mice also had inferior bone quality, which was most prominent in females. We conclude that obesity and diabetes due to impaired leptin signaling contribute to pathological changes in vertebrae, as well as an immature IVD phenotype, particularly of females, suggesting a sex-dependent role of leptin in the spine.


2014 ◽  
Author(s):  
Silvia Pabisch ◽  
Tsuguno Yamaguchi ◽  
Yasushi Koike ◽  
Kenji Egashira ◽  
Shinsuke Kataoka ◽  
...  

2017 ◽  
Vol 31 (7) ◽  
pp. 3138-3149 ◽  
Author(s):  
Giovanna Sociali ◽  
Mirko Magnone ◽  
Silvia Ravera ◽  
Patrizia Damonte ◽  
Tiziana Vigliarolo ◽  
...  

2021 ◽  
Author(s):  
Yoichiro Kashiwagi ◽  
Syunsuke Aburaya ◽  
Naoyuki Sugiyama ◽  
Yuki Narukawa ◽  
Yuta Sakamoto ◽  
...  

Abstract Periodontal infection is thought to generate systemic inflammation, thus aggravating diabetes. Furthermore, orally administered periodontal pathogens may directly alter the gut microbiota. To elucidate this, using an obese db/db diabetes mice, orally treated with Porphyromonas gingivalis (Pg), we screened for Pg-specific peptides in intestinal fecal specimens and examined whether Pg localization affected the intestinal microbiota profile altering gut metabolite levels. Finally, we screened whether deterioration of fasting hyperglycemia was related to changes in intrahepatic glucose metabolism, using proteome and metabolome analyses. As results; (1) Oral Pg treatment aggravated both fasting and postprandial hyperglycemia (P < 0.05) with a significant (P < 0.01) increase in dental alveolar bone resorption. (2) Pg-specific peptides were identified in fecal specimens after oral Pg treatment and intestinal Pg profoundly altered gut microbiome profiles at the phylum, family, and genus levels. Prevotella showed the largest increase in abundance. Furthermore, Pg-treatment significantly altered intestinal metabolite levels. (3) Fasting hyperglycemia was associated with increases in gluconeogenesis-related enzyme and metabolite levels without changes in proinflammatory cytokine expressions and insulin resistance. This work reveals that oral Pg administration induced gut microbiota changes, leading to entero-hepatic metabolic derangements, thereby aggravating hyperglycemia in an obese type 2 diabetes mouse model.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yoichiro Kashiwagi ◽  
Shunsuke Aburaya ◽  
Naoyuki Sugiyama ◽  
Yuki Narukawa ◽  
Yuta Sakamoto ◽  
...  

AbstractPeriodontal infection induces systemic inflammation; therefore, aggravating diabetes. Orally administered periodontal pathogens may directly alter the gut microbiota. We orally treated obese db/db diabetes mice using Porphyromonas gingivalis (Pg). We screened for Pg-specific peptides in the intestinal fecal specimens and examined whether Pg localization influenced the intestinal microbiota profile, in turn altering the levels of the gut metabolites. We evaluated whether the deterioration in fasting hyperglycemia was related to the changes in the intrahepatic glucose metabolism, using proteome and metabolome analyses. Oral Pg treatment aggravated both fasting and postprandial hyperglycemia (P < 0.05), with a significant (P < 0.01) increase in dental alveolar bone resorption. Pg-specific peptides were identified in fecal specimens following oral Pg treatment. The intestinal Pg profoundly altered the gut microbiome profiles at the phylum, family, and genus levels; Prevotella exhibited the largest increase in abundance. In addition, Pg-treatment significantly altered intestinal metabolite levels. Fasting hyperglycemia was associated with the increase in the levels of gluconeogenesis-related enzymes and metabolites without changes in the expression of proinflammatory cytokines and insulin resistance. Oral Pg administration induced gut microbiota changes, leading to entero-hepatic metabolic derangements, thus aggravating hyperglycemia in an obese type 2 diabetes mouse model.


2019 ◽  
Vol 1865 (9) ◽  
pp. 2276-2284 ◽  
Author(s):  
Kavya Tamarai ◽  
Jasvinder Singh Bhatti ◽  
P. Hemachandra Reddy

2006 ◽  
Vol 20 (4) ◽  
Author(s):  
Jennifer M. Fortuna ◽  
Ola A. Mostafa ◽  
Taryn P. Stewart ◽  
Jung Han Kim

2014 ◽  
Author(s):  
Felix Repp ◽  
Philip Kollmannsberger ◽  
Andreas Roschger ◽  
Paul Roschger ◽  
Wolfgang Wagermaier ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Hiroyuki Kose ◽  
Takahisa Yamada ◽  
Kozo Matsumoto

Obesity has been considered one of the leading causative agents for diseases such as type 2 diabetes, stroke, and heart attack. Due to their complex etiology, establishing auseful animal model is increasingly crucial for better molecular understanding of how obesity influences on disease development. OLETF rat is a spontaneous model of type 2 diabetes. We mapped 14 hyperglycemia QTLs in the genome of the OLETF rat and subsequently generated a panel of congenic strains each possessing OB-R mutation in F344 genetic background. Here we show that one of the loci,Nidd2/of, is highly responsive to obesity. When leptin receptor mutation is introgressed into theNidd2/ofcongenic strain, the rat showed hyperglycemia equivalent to that of the parental OLETF rat. This suggests that theNidd2/oflocus has a strong genetic interaction with leptin signaling pathway. Furthermore, when another hyperglycemiaQTL Nidd1/ofis additionally combined, the strain developed overt diabetes. A single QTL dissected out in spontaneous model normally exerts only mild effect on the quantitative trait, which makes it difficult to clone the gene. Our new model may help not only to identify the causative gene but also to investigate how obesity interacts with a QTL to regulate diabetic traits.


Sign in / Sign up

Export Citation Format

Share Document